← FDA DRUG APPROVALS

FDA ANDA · ANDA084486

METHOCARBAMOL

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA084486
TYPE
ANDA
ORIGINAL APPROVAL
1975-05-16
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHOCARBAMOLDiscontinued
METHOCARBAMOL 750MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 50AP
1994-12-23Manufacturing (CMC) · Supplement 49AP
1994-10-11Manufacturing (CMC) · Supplement 48AP
1992-04-03Manufacturing (CMC) · Supplement 47AP
1992-04-03Manufacturing (CMC) · Supplement 45AP
1989-03-03Labeling · Supplement 44AP
1987-12-17Manufacturing (CMC) · Supplement 41AP
1987-03-25Manufacturing (CMC) · Supplement 42AP
1986-05-07Manufacturing (CMC) · Supplement 39AP
1986-03-07Manufacturing (CMC) · Supplement 37AP
1985-10-22Manufacturing (CMC) · Supplement 33AP
1984-03-23Manufacturing (CMC) · Supplement 34AP
1983-06-10Manufacturing (CMC) · Supplement 32AP
1983-02-17Manufacturing (CMC) · Supplement 31AP
1975-05-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →